Observational studies on evaluating the safety and adverse effects of traditional Chinese medicine

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Lai, Jung Nein ^a,b   Tang, Jin Ling ^c,d   Wang, Jung Der ^e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; CHINESE DRUG; DUHUO JISHENG TANG; MU TONG; SUAN ZAO REN TANG; TMN 1; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADVERSE DRUG REACTION; BLOOD CELL COUNT; CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; COUGHING; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ECCHYMOSIS; EVIDENCE BASED MEDICINE; FEVER; GINGIVA BLEEDING; HEADACHE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MOUTH ULCER; MUSCLE CRAMP; NAUSEA; OBSERVATIONAL STUDY; OSTEOARTHRITIS; PETECHIA; PHARYNGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; RETROSPECTIVE STUDY; REVIEW; RHINITIS; RISK ASSESSMENT; SIDE EFFECT; SKIN DISCOLORATION; SKIN PRURITUS; SOMNOLENCE; STOMACH PAIN; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINARY TRACT CANCER; URTICARIA; VOMITING;

EID: 84885337592     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/697893     Document Type: Review

References (49)

1. Jong M.-S., Hwang S.-J., Chen Y.-C., Chen T.-J., Chen F.-J., Chen F.-P., Prescriptions of chinese herbal medicine for constipation under the National Health Insurance in Taiwan. Journal of the Chinese Medical Association 2010 73 7 375 383 2-s2.0-77955265433 10.1016/S1726-4901(10)70081-2
2. Chuang C.-H., Hsieh W.-S., Guo Y. L., Tsai Y.-J., Chang P.-J., Lin S.-J., Chen P.-C., Chinese herbal medicines used in pregnancy: a population-based survey in Taiwan. Pharmacoepidemiology and Drug Safety 2007 16 4 464 468 2-s2.0-34247525033 10.1002/pds.1332 (Pubitemid 46656868)
3. Thomas K. J., Nicholl J. P., Coleman P., Use and expenditure on complementary medicine in England: a population based survey. Complementary Therapies in Medicine 2001 9 1 2 11 2-s2.0-0035098551 10.1054/ctim.2000.0407 (Pubitemid 32203876)
4. Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M., Kessler R. C., Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Journal of the American Medical Association 1998 280 18 1569 1575 2-s2.0-0032508952 (Pubitemid 28520643)
5. Hong C. D., Complementary and alternative medicine in Korea: current status and future prospects. Journal of Alternative and Complementary Medicine 2001 7 1 S33 S40 2-s2.0-0035686680 (Pubitemid 34072556)
6. The Committee on Chinese Medicine and Pharmacy, Department of Health Executive Yuan, Taipei City, Taiwan, List of 100 unified formulas, March 2011, http://www.ccmp.gov.tw/information/formula-type.asp?relno=549&level=C
7. Flower A., Witt C., Liu J. P., Ulrich-Merzenich G., Yu H., Lewith G., Guidelines for randomised controlled trials investigating Chinese herbal medicine. Journal of Ethnopharmacology 2012 140 3 550 554 2-s2.0-84859005147 10.1016/j.jep.2011.12.017
8. Tang J.-L., Research priorities in traditional Chinese medicine. British Medical Journal 2006 333 7564 391 394 2-s2.0-33747614152 (Pubitemid 44298069)
9. Tang J.-L., Zhan S.-Y., Ernst E., Review of randomised controlled trials of traditional Chinese medicine. British Medical Journal 1999 318 7203 160 161 2-s2.0-0033578151 (Pubitemid 29326900)
10. Tang J.-L., Liu B.-Y., Ma K.-W., Traditional Chinese medicine. The Lancet 2008 372 9654 1938 1940 2-s2.0-57049180113 10.1016/S0140-6736(08)61354-9
11. Verhoef M. J., Lewith G., Ritenbaugh C., Boon H., Fleishman S., Leis A., Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT. Complementary Therapies in Medicine 2005 13 3 206 212 2-s2.0-24344496141 10.1016/j.ctim.2005.05.001 (Pubitemid 41258550)
12. Hyland M. E., Methodology for the scientific evaluation of complementary and alternative medicine. Complementary Therapies in Medicine 2003 11 3 146 153 2-s2.0-0345308437 10.1016/S0965-2299(03)00070-0 (Pubitemid 37484113)
13. Efficace F., Horneber M., Lejeune S., Van Dam F., Leering S., Rottmann M., Aaronson N. K., Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology. Journal of Clinical Epidemiology 2006 59 12 1257 1265 2-s2.0-33750811711 10.1016/j.jclinepi.2006.03.006 (Pubitemid 44711985)
14. Bhardwaj N., Jain K., Arora S., Bharti N., A comparison of three vasopressors for tight control of maternal blood pressure during cesarean section under spinal anesthesia: effect on maternal and fetal outcome. Journal of Anaesthesiology Clinical Pharmacology 2013 29 1 26 31
15. Carrara V. I., Lwin K. M., Phyo A. P., Ashley E., Wiladphaingern J., Sriprawat K., Rijken M., Boel M., McGready R., Proux S., Chu C., Singhasivanon P., White N., Nosten F., Malaria burden and artemisinin resistance in the mobile and migrant population on the thai-myanmar border, 1999-2011: an observational study. PLoS Medicine 2013 10 3 e1001398
16. Bunchorntavakul C., Reddy K. R., Review article: herbal and dietary supplement hepatotoxicity. Alimentary Pharmacology & Therapeutics 2013 37 1 3 17
17. Vanherweghem J.-L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelen-Fastre R., Vanhaelen M., Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. The Lancet 1993 341 8842 387 391 2-s2.0-0027512619 10.1016/0140-6736(93)92984-2 (Pubitemid 23048140)
18. Hsieh S.-C., Lai J.-N., Chen P.-C., Chen H.-J., Wang J.-D., Development of active safety surveillance system for traditional Chinese medicine: an empirical study in treating climatic women. Pharmacoepidemiology and Drug Safety 2006 15 12 889 899 2-s2.0-33845657789 10.1002/pds.1340 (Pubitemid 44941642)
19. Naranjo C. A., Busto U., Sellers E. M., A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 1981 30 2 239 245 2-s2.0-0019799332 (Pubitemid 12149145)
20. Howland R. H., Understanding and assessing adverse drug reactions. Journal of Psychosocial Nursing and Mental Health Services 2011 49 10 13 15 2-s2.0-80054725653 10.3928/02793695-20110915-01
21. Lai J.-N., Chen H.-J., Chen C.-C., Lin J.-H., Hwang J.-S., Wang J.-D., Duhuo Jisheng Tang for treating osteoarthritis of the knee: a prospective clinical observation. Chinese Medicine 2007 2 article 4 2-s2.0-34250850714 10.1186/1749-8546-2-4
22. Yeh C.-H., Arnold C. K., Chen Y.-H., Lai J.-N., Suan Zao Ren Tang as an original treatment for sleep difficulty in climacteric women: a prospective clinical observation. Evidence-Based Complementary and Alternative Medicine 2011 2011 8 2-s2.0-79959213379 10.1155/2011/673813 673813
23. Lai J.-N., Hwang J.-S., Chen H.-J., Wang J.-D., Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women. Journal of Alternative and Complementary Medicine 2005 11 6 1075 1084 2-s2.0-31144476549 10.1089/acm.2005.11.1075 (Pubitemid 43134057)
24. Lue J. G. Y., Essential Prescriptions of the Golden Coffer 2008 Paradigm Publication. http://www.paradigm-pubs.com/catalog/detail/JinGui
25. Drew A. K., Whyte I. M., Bensoussan A., Dawson A. H., Zhu X., Myers S. P., Chinese herbal medicine toxicology database: monograph on herba asari, 'Xi Xin'. Journal of Toxicology-Clinical Toxicology 2002 40 2 169 172 2-s2.0-0036310755 10.1081/CLT-120004405 (Pubitemid 34755583)
26. The Committee on Chinese Medicine and Pharmacy Department of Health, Executive Yuan, Analysis and Specification of Aristolochic Acid in Xixin 2008 Taipei City, Taiwan. http://www.ccmp.gov.tw/public/public.asp?selno= 601&relno=601&level=C
27. Hashimoto K., Higuchi M., Makino B., Sakakibara I., Kubo M., Komatsu Y., Maruno M., Minoru Okada M. O., Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. Journal of Ethnopharmacology 1999 64 2 185 189 2-s2.0-0033033959 10.1016/S0378-8741(98) 00123-8 (Pubitemid 29130101)
28. The Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan,. Reference list of registered Chinese herbal medicines, Taipei City, Taiwan, Nomember 2008, http://www.ccmp.gov.tw/public/public.asp?selno= 492&relno=492&level=C
29. Hsieh S.-C., Lin I.-H., Tseng W.-L., Lee C.-H., Wang J.-D., Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chinese Medicine 2008 3 article 13 2-s2.0-56449129467 10.1186/1749-8546-3-13
30. The Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan, Drug Registration-Related Regulations-Xixin Herbs and Products 2008 Taipei City, Taiwan. http://www.ccmp.gov.tw/public/public.asp?selno= 601&relno=601&level=C
31. Sun S., Qianjin Yaofang (Invaluable Prescriptions for Ready Reference) 2008 Taipei, Taiwan National Palace Museum. http://www.npm.gov.tw/exh92/ medicinal9207/english/content/m4.htm
32. Yang H.-Y., Lin J.-L., Chen K.-H., Yu C.-C., Hsu P.-Y., Lin C.-L., Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin. Journal of Nephrology 2006 19 1 111 114 2-s2.0-33645462643
33. Hsieh P. H., Hsiao F. Y., Gau S. S., Gau C. S., Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study. Journal of Clinical Psychopharmacology 2013 33 3 299 305
34. Su V. Y., Hu Y. W., Chou K. T., Ou S. M., Lee Y. C., Lin E. Y., Chen T. J., Tzeng C. H., Liu C. J., Amiodarone and the risk of cancer: a nationwide population-based study. The Cancer Journal 2013 119 9 1669 1705
35. Huang W. S., Tsai C. H., Lin C. C., Muo C. H., Sung F. C., Chang Y. J., Kao C. H., Relationship between zolpidem use and stroke risk: a Taiwanese population-based case-control study. Journal of Clinical Psychiatry 2012 74 5 e433 e438
36. Lin Y. T., Liu C. J., Yeh Y. C., Chen T. J., Fung C. P., Ampicillin and amoxicillin use and the risk of Klebsiella pneumoniae liver abscess in Taiwan. The Journal of Infectious Diseases 2013 208 2 211 217
37. Price R. G., The role of NAG (N-acetyl- β -D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clinical Nephrology 1992 38 1 S14 S19 2-s2.0-0027075199 (Pubitemid 23092540)
38. Lai J.-N., Hsieh S.-C., Chen P.-C., Chen H.-J., Wang J.-D., Should herbs take all the blame? Causality assessment of a serious thrombocytopenia event. Journal of Alternative and Complementary Medicine 2010 16 11 1221 1224 2-s2.0-78249250845 10.1089/acm.2010.0057
39. Lai M.-N., Lai J.-N., Chen P.-C., Hsieh S.-C., Hu F.-C., Wang J.-D., Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. American Journal of Kidney Diseases 2010 55 3 507 518 2-s2.0-77049088904 10.1053/j.ajkd.2009.10.055
40. Lai M.-N., Lai J.-N., Chen P.-C., Tseng W.-L., Chen Y.-Y., Hwang J.-S., Wang J.-D., Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology 2009 14 2 227 234 2-s2.0-64049117979 10.1111/j.1440-1797.2008.01061.x
41. Lai M.-N., Wang S.-M., Chen P.-C., Chen Y.-Y., Wang J.-D., Population-based case-control study of chinese herbal products containing aristolochic acid and urinary tract cancer risk. Journal of the National Cancer Institute 2010 102 3 179 186 2-s2.0-76349101626 10.1093/jnci/djp467
42. Stel V. S., Jager K. J., Zoccali C., Wanner C., Dekker F. W., The randomized clinical trial: an unbeatable standard in clinical research? Kidney International 2007 72 5 539 542 2-s2.0-34548163838 10.1038/sj.ki.5002354 (Pubitemid 47312791)
43. Hsieh S.-C., Lai J.-N., Chen P.-C., Chen C.-C., Chen H.-J., Wang J.-D., Is Duhuo Jisheng Tang containing Xixin safe? A four-week safety study. Chinese Medicine 2010 5 article 6 2-s2.0-77649135451 10.1186/1749-8546-5-6
44. Yang H. Y., Wang J. D., Lo T. C., Chen P. C., Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists. Journal of Urology 2013 189 1 48 52
45. Yang H.-Y., Wang J.-D., Lo T.-C., Chen P.-C., Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids. Occupational and Environmental Medicine 2011 68 4 286 290 2-s2.0-79952574878 10.1136/oem.2010.058594
46. Vandenbroucke J. P., When are observational studies as credible as randomised trials? The Lancet 2004 363 9422 1728 1731 2-s2.0-2442649987 10.1016/S0140-6736(04)16261-2 (Pubitemid 38670333)
47. Klungel O. H., Martens E. P., Psaty B. M., Grobbee D. E., Sullivan S. D., Stricker B. H. C., Leufkens H. G. M., De Boer A., Methods to assess intended effects of drug treatment in observational studies are reviewed. Journal of Clinical Epidemiology 2004 57 12 1223 1231 2-s2.0-11144249296 10.1016/j.jclinepi.2004.03.011 (Pubitemid 40023141)
48. Vray M., Hamelin B., Jaillon P., The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs. Therapie 2005 60 4 339 349 2-s2.0-29144467046 10.2515/therapie:2005047 (Pubitemid 41798098)
49. Winslow L. C., Shapiro H., Physicians want education about complementary and alternative medicine to enhance communication with their patients. Archives of Internal Medicine 2002 162 10 1176 1181 2-s2.0-0037182037 (Pubitemid 34522407)